Keywords: debiopharm, licenses, canadian, sanvar, ir, rights, med

Debiopharm licenses Canadian Sanvar IR rights to Med Futures

Article | 03 March 2008

Swiss firm Debiopharm has signed a license and supply agreement with Medical Futures, a Canadian gastroenterology-focused speciality pharmaceutical company, for ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in